Ran Zhao
- Cancer Research top 2%
- MicroRNA in disease regulation 10
- Cancer-related molecular mechanisms research 5
- Molecular Biology top 10%
- Glycosylation and Glycoproteins Research 9
- Chromatin Remodeling and Cancer 7
- RNA modifications and cancer 7
- Circular RNAs in diseases 5
- Immunology top 10%
- Galectins and Cancer Biology 6
- Oncology top 10%
- Peptidase Inhibition and Analysis 5
- Co-authors
- Guiyuan LiYukun LiuWeihong NiuJunfeng ZhangJianxin GuChen‐Yu ZhangJiangning ChenMing Zhou
- Journals
- Scientific Reports (4 papers)Journal of Proteomics (3 papers)Clinical Proteomics (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ran Zhao
58 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 126
- Cancer Research 655
- Molecular Biology 1.1k
- Immunology 271
- Oncology 302
- Cell Biology 96
Countries citing papers authored by Ran Zhao
This map shows the geographic impact of Ran Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Zhao more than expected).
Fields of papers citing papers by Ran Zhao
This network shows the impact of papers produced by Ran Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Zhao. The network helps show where Ran Zhao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ran Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 8 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 0 | |
| 6 | 2021 | 19 | |
| 7 | 2020 | 49 | |
| 8 | 2020 | 13 | |
| 9 | 2020 | 6 | |
| 10 | 2019 | 222 | |
| 11 | 2018 | 14 | |
| 12 | 2018 | 34 | |
| 13 | 2017 | 51 | |
| 14 | 2017 | 41 | |
| 15 | 2017 | 30 | |
| 16 | 2016 | 41 | |
| 17 | 2015 | 20 | |
| 18 | 2015 | 24 | |
| 19 | 2014 | 47 | |
| 20 | 2013 | 4 |
About Ran Zhao
Ran Zhao is a scholar working on Cancer Research, Oncology and Applied Microbiology and Biotechnology, having authored 64 papers that have together received 1.8k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (10 papers), Glycosylation and Glycoproteins Research (9 papers), Chromatin Remodeling and Cancer (7 papers), RNA modifications and cancer (7 papers), Galectins and Cancer Biology (6 papers), Peptidase Inhibition and Analysis (5 papers), Cancer-related molecular mechanisms research (5 papers) and Circular RNAs in diseases (5 papers). The work is most often cited by research in Cancer Research (655 citations), Molecular Biology (1.1k citations) and Immunology (271 citations). Ran Zhao has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Guiyuan Li, Yukun Liu, Weihong Niu, Junfeng Zhang, Jianxin Gu, Chen‐Yu Zhang, Jiangning Chen, Ming Zhou, Mengna Li and Chunchun Wu. Their work appears in journals such as Scientific Reports, Journal of Proteomics, Clinical Proteomics, Journal of Cancer and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.